Composition
- Active ingredients
- TACROLIMUS EQ 4MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- TACROLIMUS EQ 1MG BASE · Tablet, extended releaseNDA206406-002 · Prescription
- TACROLIMUS EQ 4MG BASE · Tablet, extended releaseThis page
- TACROLIMUS EQ 0.75MG BASE · Tablet, extended releaseNDA206406-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA206406.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.